Physician profile
Hemant Goyal
NPI 1205106796
$8,326.86
in general payments reported to CMS, 2019-2025
35 companies · $2,132 in 2025
The $2,132 reported for 2025 was more than what 80% of Gastroenterology (Internal Medicine) providers received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $42.08 · 2020: $1,041 · 2021: $350 · 2022: $902 · 2023: $2,083 · 2024: $1,777 · 2025: $2,132.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,744 · Travel and Lodging: $230 · Education: $16.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,744.43 |
| Travel and Lodging | $230.46 |
| Education | $16.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,623.22 | 2021-2025 | |
| Olympus Corporation of The Americas | $1,041.21 | 2020 | |
| Janssen Biotech, INC. | $641.03 | 2022-2025 | Tremfya, Stelara, Simponi Aria |
| Madrigal Pharmaceuticals | $592.19 | 2024-2025 | Rezdiffra, Resmetirom |
| Boston Scientific Corporation | $530.67 | 2022-2023 | Orise |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $498.38 | 2021-2025 | Xifaxan, Trulance |
| Apollo Endosurgery US INC | $465.66 | 2023 | Overstitch Endoscopic Suturing System, Orbera Intragastric Balloon System |
| Medtronic, INC. | $388.08 | 2022-2025 | Gi Genius |
| Aimmune Therapeutics, INC. | $293.85 | 2024-2025 | Zenpep |
| Conmed Corporation | $268.67 | 2023 | Conmed Generators |
| Fujifilm Healthcare Americas Corporation | $262.87 | 2023 | Fujifilm |
| Phathom Pharmaceuticals, INC. | $215.83 | 2024-2025 | Voquezna |
| Genzyme Corporation | $196.39 | 2024-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $192.30 | 2022-2025 | Entyvio, Gattex |
| Janssen Scientific Affairs, LLC | $124.74 | 2021 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $124.32 | 2024-2025 | Omvoh |
| Pfizer INC. | $122.17 | 2019-2025 | |
| Gilead Sciences, INC. | $111.73 | 2021-2024 | |
| Olympus America INC. | $89.77 | 2023 | Endoclot Phs, Endoclot Sis, Endocuff Vision |
| Merck Sharp & Dohme LLC | $86.91 | 2022-2024 | Dificid, Zinplava |
| Ethicon US, LLC | $86.43 | 2023 | Linx Reflux Management System |
| Ironwood Pharmaceuticals, INC | $81.98 | 2023-2025 | Linzess |
| Regeneron Healthcare Solutions, INC. | $67.22 | 2023-2025 | Dupixent |
| Ardelyx, INC. | $27.74 | 2024 | Ibsrela |
| Alnylam Pharmaceuticals INC. | $25.76 | 2024 | Givlaari |
| Erbe USA INC | $25.42 | 2022 | |
| Intercept Pharmaceuticals, INC. | $25.36 | 2024 | |
| Nestle Healthcare Nutrition INC. | $22.78 | 2023 | |
| Mallinckrodt Hospital Products INC. | $18.50 | 2023 | Terlivaz |
| Celltrion USA INC. | $16.99 | 2024 | Zymfentra |
| Astrazeneca Pharmaceuticals LP | $16.27 | 2019 | |
| Qol Medical, LLC | $15.82 | 2022 | |
| Amgen INC. | $13.46 | 2025 | Uplizna |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $13.14 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hemant Goyal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.